GI Adverse Events With Insulin Glargine/Lixisenatide Fixed-Ratio Combination vs. GLP-1 RAs in T2DM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gastrointestinal Adverse Events With Insulin Glargine/Lixisenatide Fixed-Ratio Combination Versus GLP-1 RAs in People With Type 2 Diabetes Mellitus: A Network Meta-Analysis
Diabetes Obes Metab 2020 Sep 29;[EPub Ahead of Print], CK Rayner, T Wu, VR Aroda, C Whittington, S Kanters, P Guyot, A Shaunik, M HorowitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.